-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
LakeShore Biopharma Co., Ltd. quarterly Deferred Tax Assets, Gross history and growth rate for Q1 2024.
- LakeShore Biopharma Co., Ltd. Deferred Tax Assets, Gross for the quarter ending March 31, 2024 was $3.77M.
Deferred Tax Assets, Gross, Quarterly (USD)